Doses nearly four hundred mg/day, offered as an individual dose, are well tolerated, but there is no regular proof that this dose confers additional profit past that of the 200 mg/day dose [see CLINICAL PHARMACOLOGY and Scientific Experiments].This proprietary technique, which was established by trained computer software engineers, permits to map,